Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-58.41	71.06	170.86
Graham Fair Price	41.43	2.02	1.43
PEG	-76.30	0.02	-0.10
Price/Book	-22.89	0.06	0.08
Price/Cash Flow	77.04	-19.52	-84.98
Prices/Earnings	-61.45	2.34	6.06
Price/Sales	-61.36	16.89	43.73
Price/FCF	77.04	-19.52	-84.98
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-13.88	0.82	0.95
Operating Margin	-0.58	0.27	0.27
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	109.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	-80.59
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.38	0.98	160.11
EPS QOQ	-0.61	1.00	62.64
FCF QOQ	0.71	-2.36	229.74
Revenue QOQ	-0.48	1.00	105.87
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	9017.90	1167.95	-87.05
Days Sales Outstanding (DSO)	19.66	1.86	-90.54
Inventory Turnover	< 0.005	0.08	672.11
Debt/Capitalization	0.04	0.04	0.06
Quick Ratio	2.88	2.81	-2.24
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	5.31	5.31	< 0.005
Cash	0.07	0.07	< 0.005
Capex	< 0.005	< 0.005	-100.01
Free Cash Flow	< 0.005	-0.02	-235.77
Revenue	< 0.005	0.02	99.58
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	4.58	4.58	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	47.59	23.72	-50.15
Naive Interpretation	Member

06 - Financial Health · Bad

Rating